Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/29/2012US20120077813 Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease
03/29/2012US20120077812 Bicyclic compounds and use as antidiabetics
03/29/2012US20120077811 Prodrug forms of kinase inhibitors and their use in therapy
03/29/2012US20120077810 Inhibitors Of AKT Activity
03/29/2012US20120077809 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077805 Unsolvated benzodiazepine compositions and methods
03/29/2012US20120077803 Uses Of NK Receptor Antagonists
03/29/2012US20120077802 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/29/2012US20120077801 Chemical Compounds 637
03/29/2012US20120077800 Methods for Treating Antipsychotic-Induced Weight Gain
03/29/2012US20120077799 Heterocyclic compound and use thereof
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077797 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
03/29/2012US20120077796 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077793 Compounds for the Treatment of Metabolic Disorders
03/29/2012US20120077792 Lanthanide metal complexes useful in treating cancer
03/29/2012US20120077791 Novel crystalline form of antiprogestin cdb-4124
03/29/2012US20120077790 Ulipristal Acetate Tablets
03/29/2012US20120077789 Method for treatment of diseases
03/29/2012US20120077788 Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains; pharmaceutical composition containing telocinobufagin and its use
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077786 Methods and compositions for disease treatment using inhalation
03/29/2012US20120077785 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
03/29/2012US20120077784 Skin treatment compositions
03/29/2012US20120077783 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
03/29/2012US20120077782 Method of activation of oxazaphosphorines
03/29/2012US20120077781 Flavin derivatives
03/29/2012US20120077780 Fat Accumulation Inhibitor and Method of Use Thereof
03/29/2012US20120077779 Inhibitors of Fibroblast Activation Protein Alpha
03/29/2012US20120077778 Ladder-Frame Polyether Conjugates
03/29/2012US20120077777 Ngcycloartanone derivatives with anticancer activity
03/29/2012US20120077776 Hydrolysis resistant organomodified trisiloxane surfactants
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077774 Compositions and their use for removing cholesterol
03/29/2012US20120077773 Use of a composition for the treatment of mucositis
03/29/2012US20120077772 Solid oral dosage forms of lamivudine
03/29/2012US20120077771 Compositions for use in cardioplegia comprising esmolol and adenosine
03/29/2012US20120077770 Methods of Diagnosing and Treating Multiple Sclerosis
03/29/2012US20120077769 Topical ophthalmic compositions containing tobramycin and dexamethasone
03/29/2012US20120077768 Stabilized and lyophilized formulation of anthracycline compounds
03/29/2012US20120077767 Molecular predictors of fungal infection
03/29/2012US20120077766 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
03/29/2012US20120077765 Isoxazoline oximes as antiparasitic agents
03/29/2012US20120077764 Compositions and method for treating infection in cattle and swine
03/29/2012US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)
03/29/2012US20120077762 Compositions and methods for the prevention and treatment of heart failure
03/29/2012US20120077761 Compositions and methods for the prevention and treatment of coronary heart diseases
03/29/2012US20120077760 Novel salts of sitagliptin
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120077757 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair
03/29/2012US20120077754 Copolymer-1 improvements in compositions of copolymers
03/29/2012US20120077753 Jnk inhibitors for use in treating spinal muscular atrophy
03/29/2012US20120077751 Methods for modulating neuronal responses
03/29/2012US20120077750 Use of a growth-stimulating protein
03/29/2012US20120077748 Materials and Methods for Improving Gastrointestinal Function
03/29/2012US20120077739 Methods for treating obesity employing an sglt2 inhibitor and compositions thereof
03/29/2012US20120077734 Methods and assays for treating conditions in which macrophages play a pathogenic role
03/29/2012US20120077730 Method for in Vitro Molecular Evolution of Protein Function
03/29/2012US20120077676 Antifungal 1,2,4-Triazolyl Derivatives Having a 5-Sulfur Substituent
03/29/2012US20120076877 Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof
03/29/2012US20120076872 Modified green tea polyphenol formulations
03/29/2012US20120076866 Particulate pharmaceutical composition
03/29/2012US20120076865 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
03/29/2012US20120076863 Nanoparticulate stabilized anti-hypertensive compositions
03/29/2012US20120076859 Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
03/29/2012US20120076857 Forms of rifaximin and uses thereof
03/29/2012US20120076856 Orodispersible pharmaceutical composition of perindopril
03/29/2012US20120076855 Oral testosterone composition
03/29/2012US20120076853 Composition for use in gene therapy
03/29/2012US20120076852 Drug carrier and drug carrier kit for inhibiting fibrosis
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076850 Topical Patch For Pain Relief Using Cooling Agent
03/29/2012US20120076848 Method and system for effecting changes in pigmented tissue
03/29/2012US20120076838 Poorly soluble drug containing microsphere with improved bioavailabilty and method of preparing the same
03/29/2012US20120076836 Polyion complex of double-stranded ribonucleic acid
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076834 Protective Coatings For Acidic Active Ingredients
03/29/2012US20120076832 Synthesis and use of therapeutic metal ion containing polymeric particles
03/29/2012US20120076828 Kanamycin antisense nucleic acid for the treatment of cancer
03/29/2012US20120076823 Vector
03/29/2012US20120076807 Plasmids with immunological action
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076788 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
03/29/2012US20120076781 Methods of treating cancers with her3 antisense oligonucleotides
03/29/2012US20120076777 Anti-fibroblastic fluorochemical emulsion therapies
03/29/2012US20120076776 Method for treating inflamation by lymphocyte depletion or sequestering
03/29/2012US20120076775 Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
03/29/2012US20120076770 Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases
03/29/2012US20120076768 Digestive/laxative compositions
03/29/2012US20120076766 Topical drug delivery system with dual carriers
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/29/2012US20120076756 Novel benzimidazole derivatives
1 ... 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 ... 7860